Ingrid Glimelius
Anknuten till Forskning
E-postadress: ingrid.glimelius@ki.se
Besöksadress: Maria Aspmans gata 30A, 17164 Solna
Postadress: K2 Medicin, Solna, K2 KEP Ekström Smedby, 171 77 Stockholm
Om mig
- Jag är överläkare i Onkologi och arbetar med patienter som har drabbats av
lymfom eller testikelcancer. Jag arbetar som läkare på onkologkliniken,
Akademiska Sjukhuset Uppsala.
Utöver detta bedriver jag forskningsstudier med syfte att förbättra för
de som drabbats av dessa cancersjukdomar.
Sedan 2002 har jag varit involverad i lymfomforskning och sedan 2011 har jag
samarbetat med Karin Ekström Smedby (https://ki.se/people/kariek [1]) och
varit anknuten till cancerepidemiologigruppen vid Enheten för Klinisk
Epidemiologi, Karolinska Institutet. Utöver mitt kliniska arbete är jag
ansvarig för kliniska fas I-III studier, epidemiologiska studier och
handleder doktorander. Jag har ett stort intresse för undervisning och
undervisar både läkarstudenter och blivande specialistläkare
Leg Läkare, Uppsala Universitet 2001
PHD, Uppsala Universitet 2009, Avhandling: /Hodgkin lymphoma – an
interplay between tumour cell and microenvironment./
Specialist Internmedicin 2011
Specialist Onkologi 2013
Docent i Onkologi 2016
Good Clinical Practice, Investigator Site Personnel ICH-GCP
Överläkare Onkologi 2019
Lektor Uppsala Universitet 2021-
[1] https://ki.se/people/kariek
Forskningsbeskrivning
- En beskrivning av min forskning finns på den engelskspråkiga sidan
https://ki.se/en/people/inggli [1].
[1] https://ki.se/en/people/inggli
Undervisning
- Jag undervisar på läkarutbildningen och handleder regelbundet
läkarstudenter samt blivande specialistläkare framförallt om orsak,
diagnostik, behandling och omhändertagande av patienter med olika lymfatiska
maligniteter.
Kursanvarig läkarutbildningen i Onkologi Uppsala Universitet 2012
Högskolepedagogisk Grundkurs 2014
Good Clinical Practice, Investigator Site Personnel ICH-GCP
Examinator projektarbeten läkarutbildningen Uppsala Universitet, sedan 2017-
Bred undervisningserfarenhet på både grund och specialiserad nivå
Styrgruppen för Nationella Forskar Skolan i Onkologi, NATION 2019-
Immunterapi och tumörens mikromiljö, kursansvarig 2019-
Artiklar
- Article: EJHAEM. 2024;5(5):998-1004
- Article: BLOOD. 2024;144(9):1001-1009
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2024;205(2):542-551
- Article: CANCER CAUSES & CONTROL. 2024;35(8):1101-1109
- Article: ACTA ONCOLOGICA. 2024;63:563-572
- Article: HEMASPHERE. 2024;8(7):e121
- Article: BJU INTERNATIONAL. 2024;133(6):717-724
- Article: CANCER CAUSES & CONTROL. 2024;35(5):741-747
- Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2024;46:100785
- Article: HAEMATOLOGICA. 2024;109(4):1171-1183
- Article: JCO CLINICAL CANCER INFORMATICS. 2024;8:e2300255
- Article: JOURNAL OF CANCER SURVIVORSHIP. 2024;:1-11
- Article: BLOOD ADVANCES. 2024;8(2):407-415
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023;52(6):1826-1835
- Article: ACTA ONCOLOGICA. 2023;62(12):1707-1715
- Article: EUROPEAN JOURNAL OF CANCER. 2023;195:113403
- Journal article: BLOOD. 2023;142(Supplement 1):1729
- Article: BLOOD ADVANCES. 2023;7(18):5304-5313
- Article: BJU INTERNATIONAL. 2023;132(3):329-336
- Article: INTERNATIONAL JOURNAL OF CANCER. 2023;153(4):723-731
- Article: HEMASPHERE. 2023;7(8):e928
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;202(4):785-795
- Article: BRITISH JOURNAL OF CANCER. 2023;128(12):2261-2269
- Journal article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023;52(3):966
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):5008
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):477-478
- Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_suppl):tps7595
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):476-477
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41(S2):369-370
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:475-476
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:472-474
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:471-472
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:746-748
- Journal article: HEMATOLOGICAL ONCOLOGY. 2023;41 Suppl 2:474-475
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2023;32(5):687-696
- Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2023;52(2):450-465
- Article: BLOOD ADVANCES. 2023;7(5):866-874
- Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2023;192(1):70-83
- Journal article: HEMASPHERE. 2022;6(Suppl ):37-38T082: AVD - a possible golden standard in the first-line treatment of older classical Hodgkin lymphoma patients
- Journal article: HEMASPHERE. 2022;6(Suppl ):37P081: Treatment-related circulatory diseases and mortality in Hodgkin lymphoma patients using multi-state modelling and relative survival
- Journal article: HEMASPHERE. 2022;6(Suppl ):30T065: Reproduction patterns among Classical Hodgkin Lymphoma Survivors Treated with BEACOPP and ABVD in Sweden, Denmark, and Norway
- Journal article: HEMASPHERE. 2022;6(Suppl ):44P096: Polymorphisms in SETD7 may predispose the risk of developing late cardiac side effects after radiotherapy including the mediastinum in Hodgkin’ s lymphoma.
- Journal article: HEMASPHERE. 2022;6(Suppl ):42P091: Early analysis of the PRO-Hodgkin study: Clinical investigation of pencil beam scanning proton treatment in Hodgkin lymphoma patients
- Journal article: ANNALS OF ONCOLOGY. 2022;33:s1197-s1198
- Journal article: HEMASPHERE. 2022;6:103-104
- Journal article: HEMASPHERE. 2022;6(Suppl):983-984
- Journal article: CANCER RESEARCH. 2022;82(12_Supplement):2026
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2022;197(5):580-589
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(13):1487-1496
- Article: INTERNATIONAL JOURNAL OF CANCER. 2022;150(5):773-781
- Article: BLOOD CANCER JOURNAL. 2022;12(1):16
- Article: ACTA ONCOLOGICA. 2021;60(11):1459-1465
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(31):3463-3472
- Article: EJHAEM. 2021;2(3):400-412
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;193(5):906-914
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;193(3):520-531
- Article: BLOOD ADVANCES. 2021;5(6):1671-1681
- Article: BLOOD ADVANCES. 2021;5(6):1638-1647
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(3):551-559
- Article: LANCET DIABETES & ENDOCRINOLOGY. 2021;9(2):94-105
- Article: HEMASPHERE. 2021;5(1):e510
- Article: BMJ-BRITISH MEDICAL JOURNAL. 2020;371:m4060
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;191(5):796-805
- Article: ACTA ONCOLOGICA. 2020;59(8):949-958
- Article: BRITISH JOURNAL OF CANCER. 2020;123(1):161-166
- Article: EJHAEM. 2020;1(1):199-207
- Article: EUROPEAN UROLOGY ONCOLOGY. 2020;3(3):382-389
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(6):1083-1092
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;189(1):106-116
- Article: INTERNATIONAL JOURNAL OF CANCER. 2020;146(6):1523-1531
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2020;188(5):685-691
- Article: IMMUNOBIOLOGY. 2020;225(1):151872
- Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(5):1200-1208
- Article: CANCER MEDICINE. 2019;8(10):4918-4927
- Journal article: HEMASPHERE. 2019;3(S1):141-142
- Journal article: HEMATOLOGICAL ONCOLOGY. 2019;37(S2):242
- Article: PLOS MEDICINE. 2019;16(6):e1002816
- Article: JOURNAL OF INTERNAL MEDICINE. 2019;285(4):455-468
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2019;37(9):703-713
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2019;184(2):192-201
- Article: INTERNATIONAL JOURNAL OF CANCER. 2018;143(8):1904-1913
- Article: INTERNATIONAL JOURNAL OF CANCER. 2018;143(8):1858-1867
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2018;36(26):2718-2725
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(1):106-114
- Article: JOURNAL OF INTERNAL MEDICINE. 2018;283(5):430-445
- Article: RADIOTHERAPY AND ONCOLOGY. 2018;126(3):424-430
- Article: ACTA ONCOLOGICA. 2018;57(2):276-282
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;100(1):88-97
- Article: PLOS ONE. 2018;13(9):e0204870
- Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;186(10):1159-1167
- Article: BLOOD ADVANCES. 2017;1(18):1427-1439
- Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):100-101
- Journal article: HEMATOLOGICAL ONCOLOGY. 2017;35(S2):172-173
- Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2017;92(3):251-258
- Article: BRITISH JOURNAL OF CANCER. 2016;115(11):1416-1420
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;97(5):430-438
- Article: LEUKEMIA & LYMPHOMA. 2016;57(10):2351-2358
- Article: JOURNAL OF CANCER SURVIVORSHIP. 2016;10(3):514-523
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2016;25(6):987-994
- Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2016;51(5):583-589
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(4):337-344
- Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2015;24(12):1838-1843
- Article: AMERICAN JOURNAL OF HEMATOLOGY. 2015;90(12):1128-1134
- Article: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):599-609
- Article: ACTA ONCOLOGICA. 2015;54(10):1770-1780
- Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2015;182(7):624-632
- Article: BRITISH JOURNAL OF SURGERY. 2015;102(11):1426-1432
- Article: BLOOD. 2013;122(20):3492-3499
- Article: HISTOPATHOLOGY. 2012;61(1):26-32
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2011;87(3):208-216
- Article: EXPERIMENTAL HEMATOLOGY. 2011;39(8):850-858
- Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;67(1):53-56
- Article: HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA. 2007;21(5):805-823
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2006;76(4):278-283
- Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2003;71(5):327-333
- Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2003;290(4):465-475
- Article: BRITISH JOURNAL OF HAEMATOLOGY. 2002;119(1):122-124
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2002;94(3):182-192
- Visa fler
Alla övriga publikationer
- Review: JOURNAL OF INTERNAL MEDICINE. 2024;295(6):715-734
- Editorial comment: ANNALS OF ONCOLOGY. 2024;35(3):245-247
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)
- Review: FRONTIERS IN IMMUNOLOGY. 2024;15:1373269
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)
- Conference publication: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023;23:S457-S458
- Conference publication: AMERICAN JOURNAL OF HEMATOLOGY. 2023;98:S51-S52
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)
- Conference publication: JOURNAL OF UROLOGY. 2023;209:E451
- Conference publication: BLOOD. 2022;140:9411-9412
- Conference publication: BLOOD. 2022;140:1079-1081
- Conference publication: BLOOD. 2022;140:184-185
- Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S777
- Editorial comment: BRITISH JOURNAL OF HAEMATOLOGY. 2022;198(1):11-13
- Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(7):E255-E257
- Conference publication: CANCER RESEARCH. 2022;82(12)
- Conference publication: JOURNAL OF UROLOGY. 2022;207(5):E845
- Conference publication: ANNALS OF ONCOLOGY. 2021;32:S748-S749
- Letter: HAEMATOLOGICA. 2021;106(9):2502-2506
- Conference publication: BLOOD. 2020;136:3-4
- Letter: BRITISH JOURNAL OF HAEMATOLOGY. 2020;190(4):e245-e248
- Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95(2):E36-E38
- Conference publication: JOURNAL OF UROLOGY. 2020;203:E384
- Conference publication: AMERICAN JOURNAL OF HEMATOLOGY. 2020;95:S14-S15
- Conference publication: BLOOD. 2019;134:2841
- Conference publication: BLOOD. 2019;134:4572
- Review: LEUKEMIA & LYMPHOMA. 2019;60(13):3116-3131
- Conference publication: INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2019;29:A148-A149
- Preprint: SSRN ELECTRONIC JOURNAL. 2019
- Conference publication: BLOOD. 2018;132:930
- Conference publication: BLOOD. 2018;132:3120
- Conference publication: BLOOD. 2018;132:2891
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2017;35:tps4593
- Review: JOURNAL OF INTERNAL MEDICINE. 2017;281(3):247-260
- Conference publication: HAEMATOLOGICA. 2016;101:36
- Conference publication: HAEMATOLOGICA. 2016;101:3
- Conference publication: HAEMATOLOGICA. 2016;101:1-2
- Conference publication: HAEMATOLOGICA. 2016;101:64-65
- Conference publication: HAEMATOLOGICA. 2016;101:22
- Corrigendum: JOURNAL OF CANCER SURVIVORSHIP. 2015;9(4):610-611
- Letter: LEUKEMIA. 2005;19(12):2360-2362
- Visa fler
Anställningar
- Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2023-2026
Handledare
- Caroline Weibull, Survivorship in Hodgkin lymphoma : childbearing and treatment-related disease, https://openarchive.ki.se/xmlui/handle/10616/46467, 2014